Mylan’s Hostile Bid For Drug Giant Perrigo Failed
Mylan N.V. (NASDAQ: MYL; TASE) today announced that its offer to acquire all of the issued and to be issued share capital of Perrigo Company plc (NYSE: PRGO; TASE) has lapsed. Perrigo ordinary shares, More...
Mylan receives US FTC Clearance to buy Perrigo
Under the settlement agreement with the Federal Trade Commission, subject to final approval, Mylan NV has agreed to sell the rights and assets related to seven generic drugs to secure regulatory approval More...
Mylan to pitch today to Perrigo shareholders in hostile takeover bid
The hostile takeover bid for Perrigo Co. PLC continues with Mylan NV hosting a Tuesday, 5 pm, conference call to pitch the buyout to Perrigo shareholders. Perrigo has rejected the $27 billion buyout More...
The Trouble With Disney’s Great Man Theory
Disney has been a winning stock since Bob Iger took over from Michael Eisner in 2005, with the stock rising 300%. Under Eisner’s guidance, the company was faltering, with a hostile takeover bid and More...
Alpha Wolf Bill Ackman Is Top Dog on Wall Street
Bill Ackman might be controversial, but he had the top performing hedge fund of 2014, as reported by Bloomberg. While he was ridiculed the previous year for his pressure to put Ron Johnson of AppleStores as More...
Lawsuits All Around for CVR, Carl Icahn, Watchell and Banks
A legal battle is raging on between Watchell and two partners against Carl Icahn over CVR Refining, a company that was once advised by Watchell but was ultimately taken over by Icahn. CVR is alleging Watchell More...
Is Bill Ackman Guilty of Insider Trading?
Bill Ackman has cleaned up this year to the tune of $1 billion. He has also profited from Actavis’ announced merger with Botox maker Allergan, although for many months, he was pushing the company to accept More...
Actavis Saves Allergan from Valeant Hostile Takeover with $66 Billion Deal, But Will Slash R&D
The seven-month battle over American Botox haven pharmaceutical company Allergan is over, after it accepted a friendly takeover bid from Irish integrated specialty pharmaceutical Actavis. The Actavis offer More...
Bill Ackman Finally Throws in the Towel with Allergan Shareholders’ Meeting
After an intense and acrimonious months long battle for a hostile takeover of Allergan, Bill Ackman, who owns a 9.7% stake in the company, finally gave up his battle to convene a special shareholders’ More...
Jim Cramer: Ackman Is At It Again
On CNBC’s Mad Dash, Jim Cramer discussed Zoetis, an animal health biotech, that is a “gem of a company” spun off by Pfizer. Even though the company seems to be doing everything right, More...